Yonkers biotech ContraFect announces public offering of common stock
Yonkers biotech firm ContraFect Corp. has commenced an underwritten public offering of shares of its common stock. ContraFect --- a clinical-stage biotechnology company focused on…
Yonkers biotech firm ContraFect Corp. has commenced an underwritten public offering of shares of its common stock. ContraFect --- a clinical-stage biotechnology company focused on…